Since serum IL-6 levels are elevated in obese individuals, IL-6-induced GLP-1 secretion may play a role in enhancing the proliferation of β-cells to expand the reservoir of β-cells as compensation for increased insulin requirements due to the accumulation of visceral fat and subsequent exacerbation of insulin resistance [24]. Here, INS is linked to Insulin resistance.